Trial intelligence / Profile preview

Simvastatin in RRMS Patients on Avonex

NCT00668343Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Apr 2005
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of simvastatin in relapsing-remitting multiple sclerosis (RRMS), sponsored by Tehran University of Medical Sciences. Started Apr 2005; status: completed.

02

Drugs

simvastatin
03

Conditions

relapsing-remitting multiple sclerosis (RRMS)

Beyond the preview

Go deeper on NCT00668343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00668343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call